These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24316677)

  • 1. LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants.
    Andreotti G; Karami S; Pfeiffer RM; Hurwitz L; Liao LM; Weinstein SJ; Albanes D; Virtamo J; Silverman DT; Rothman N; Moore LE
    Epigenetics; 2014 Mar; 9(3):404-15. PubMed ID: 24316677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk.
    Karami S; Andreotti G; Liao LM; Pfeiffer RM; Weinstein SJ; Purdue MP; Hofmann JN; Albanes D; Mannisto S; Moore LE
    Epigenetics; 2015; 10(4):282-92. PubMed ID: 25647181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.
    Moore LE; Pfeiffer RM; Poscablo C; Real FX; Kogevinas M; Silverman D; García-Closas R; Chanock S; Tardón A; Serra C; Carrato A; Dosemeci M; García-Closas M; Esteller M; Fraga M; Rothman N; Malats N
    Lancet Oncol; 2008 Apr; 9(4):359-66. PubMed ID: 18339581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer.
    Liao LM; Brennan P; van Bemmel DM; Zaridze D; Matveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Rothman N; Boffetta P; Chow WH; Moore LE
    PLoS One; 2011; 6(11):e27361. PubMed ID: 22076155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer.
    Vermeulen R; Bodinier B; Dagnino S; Wada R; Wang X; Silverman D; Albanes D; Freedman N; Rahman M; Bell D; Chadeau-Hyam M; Rothman N
    Eur J Epidemiol; 2024 Apr; 39(4):393-407. PubMed ID: 38554236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts.
    Seow WJ; Cawthon RM; Purdue MP; Hu W; Gao YT; Huang WY; Weinstein SJ; Ji BT; Virtamo J; Hosgood HD; Bassig BA; Shu XO; Cai Q; Xiang YB; Min S; Chow WH; Berndt SI; Kim C; Lim U; Albanes D; Caporaso NE; Chanock S; Zheng W; Rothman N; Lan Q
    Cancer Res; 2014 Aug; 74(15):4090-8. PubMed ID: 24853549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial.
    Mondul AM; Weinstein SJ; Horst RL; Purdue M; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1222-5. PubMed ID: 22623707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of LINE1 methylation for bladder cancer risk in women.
    Wilhelm CS; Kelsey KT; Butler R; Plaza S; Gagne L; Zens MS; Andrew AS; Morris S; Nelson HH; Schned AR; Karagas MR; Marsit CJ
    Clin Cancer Res; 2010 Mar; 16(5):1682-9. PubMed ID: 20179218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese.
    Cash HL; Tao L; Yuan JM; Marsit CJ; Houseman EA; Xiang YB; Gao YT; Nelson HH; Kelsey KT
    Int J Cancer; 2012 Mar; 130(5):1151-9. PubMed ID: 21445976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
    Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
    J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies.
    Jacobs EJ; Newton CC; Silverman DT; Nogueira LM; Albanes D; Männistö S; Pollak M; Stolzenberg-Solomon RZ
    Cancer Causes Control; 2014 Sep; 25(9):1083-91. PubMed ID: 24913781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pooled analysis of mitochondrial DNA copy number and lung cancer risk in three prospective studies.
    Kim C; Bassig BA; Seow WJ; Hu W; Purdue MP; Shu XO; Huang WY; Liu CS; Cheng WL; Lin TT; Xiang YB; Ji BT; Gao YT; Chow WH; Männistö S; Weinstein SJ; Albanes D; Zheng W; Hosgood HD; Lim U; Rothman N; Lan Q
    Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2977-80. PubMed ID: 25293879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies.
    Douglas JB; Silverman DT; Weinstein SJ; Graubard BI; Pollak MN; Tao Y; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):359-69. PubMed ID: 21173171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer.
    Mondul AM; Weinstein SJ; Virtamo J; Albanes D
    Br J Cancer; 2012 Oct; 107(9):1589-94. PubMed ID: 22990651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of DNA methylation at LINE-1 and Alu in peripheral blood and the risk of prostate cancer.
    Barry KH; Moore LE; Liao LM; Huang WY; Andreotti G; Poulin M; Berndt SI
    Prostate; 2015 Nov; 75(15):1718-25. PubMed ID: 26250474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum vitamin D and risk of bladder cancer.
    Mondul AM; Weinstein SJ; Männistö S; Snyder K; Horst RL; Virtamo J; Albanes D
    Cancer Res; 2010 Nov; 70(22):9218-23. PubMed ID: 20978193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk.
    Tajuddin SM; Amaral AF; Fernández AF; Chanock S; Silverman DT; Tardón A; Carrato A; García-Closas M; Jackson BP; Toraño EG; Márquez M; Urdinguio RG; García-Closas R; Rothman N; Kogevinas M; Real FX; Fraga MF; Malats N;
    Br J Cancer; 2014 Apr; 110(8):2123-30. PubMed ID: 24595004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study.
    Murphy G; Cross AJ; Dawsey SM; Stanczyk FZ; Kamangar F; Weinstein SJ; Taylor PR; Männistö S; Albanes D; Abnet CC; Freedman ND
    Gut; 2018 Sep; 67(9):1646-1651. PubMed ID: 28814486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINE-1 methylation in granulocyte DNA and trihalomethane exposure is associated with bladder cancer risk.
    Salas LA; Villanueva CM; Tajuddin SM; Amaral AF; Fernandez AF; Moore LE; Carrato A; Tardón A; Serra C; García-Closas R; Basagaña X; Rothman N; Silverman DT; Cantor KP; Kogevinas M; Real FX; Fraga MF; Malats N
    Epigenetics; 2014 Nov; 9(11):1532-9. PubMed ID: 25482586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study.
    Lynch SM; Major JM; Cawthon R; Weinstein SJ; Virtamo J; Lan Q; Rothman N; Albanes D; Stolzenberg-Solomon RZ
    Int J Cancer; 2013 Dec; 133(11):2672-80. PubMed ID: 23674344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.